Diabetic Neuropathy Treatment Market 2022
According to MRFR analysis, the global Diabetic Neuropathy Treatment Market is expected to register a CAGR of 5.1% during the forecast period of 2019 to 2025 and was valued at USD 5.80 Billion by 2025.
Diabetic neuropathy is one of the most common complications of diabetes. Patients suffering from diabetic neuropathy often report burning pain in foot. The rising prevalence of diabetic neuropathy can be seen worldwide. Around 83% people in the US are suffering from diabetic neuropathy. According to Japanese study around 298 people were diagnosed with diabetic neuropathy in 2017. The growth of the global Diabetic Neuropathy Treatment Market is driven by various factors such as an increasing global geriatric population, rising prevalence of diabetes, and poor fitness levels. However, high costs of surgery are expected to curb the growth of the global Diabetic Neuropathy Treatment Market.
The global Diabetic Neuropathy Treatment Market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/diabetic-neuropathy-treatment-market-8359
Major Key Players:
Some of the key players in the global Diabetic Neuropathy Treatment Market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Lupin Limited (India), Glenmark Pharmaceuticals Limited (India), Depomed, Inc (US), Astellas Pharma Inc (Japan), Pfizer Inc (US), MEDA Pharma GmBH & Co. KG (Germany).
Segment Analysis
The global diabetic neuropathy market has been segmented based on disorder, treatment, and end user.
The market, based on disorder, has been divided into peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. The peripheral neuropathy segment is likely to be the largest during the review period due to a growing aging population and increasing prevalence of peripheral neuropathy globally. Around 1.3 million Americans are diagnosed with peripheral neuropathy every year. The autonomic neuropathy segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population.
The global Diabetic Neuropathy Treatment Market has been segmented, on the basis of treatment, into drugs, transcutaneous electrical nerve stimulation (TENS), and others. The drugs segment is expected to hold the majority share of the market. The drugs help increase muscle strength and quicken the recovery process. The transcutaneous electrical nerve stimulation segment is expected to be the fastest-growing due to the increasing use of this treatment for diabetic neuropathy. The cost of the treatment is also less as compared to other treatment types.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of diabetic neuropathy and rising per capita healthcare expenditure. The Diabetic Neuropathy Treatment Market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European Diabetic Neuropathy Treatment Market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Diabetic Neuropathy Treatment Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of diabetic neuropathy and raising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The Diabetic Neuropathy Treatment Market in the Middle East & Africa has been divided into the Middle East and Africa.
Related Reports@
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com
0
